A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

By Dahlöf Carl   Jones Martin   Davis Kim   Loftus Jane   Salonen Reijo  

The Journal of Headache and Pain, Vol. 5, Iss. 2, 2004-08 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Time to onset of efficacy of the fast-disintegrating/rapid-release formulation of sumatriptan tablets in the acute treatment of migraine

By Agosti Reto   Dahlöf Carl G.H.   Mulleners Wim M.   Jones Martin W.   Webster Chris   Few Colleen  

Headache Care, Vol. 3, Iss. 1, 2006-07 ,pp. : 3-10

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Migraine in Adolescents: A Review of Efficacy Data with Sumatriptan Nasal Spray

By Hämäläinen Mirja   Webster Christopher   Lisk Laura   Jones Martin  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 69-71

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Sumatriptan 50 mg and 100 mg Tablets Administered During the Mild Pain Phase of a Menstrually Associated Migraine Attack

By Savani N.   Boswell Diane   Loftus Jane  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 55-56

Informa Healthcare

Access to resources Recommend Favorite

A Prospective Randomized Comparison of Early vs. Late Intervention During a Migraine Attack: Early Intervention Increases the Efficacy of Sumatriptan

By Scholpp Joachim   Schellenberg Ruediger   Moeckesch Beate   Banik Norbert  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 57-59

Informa Healthcare

Access to resources Recommend Favorite